NO20000230D0 - Behandling av diabetes med tiazolidindion, insulin sekretagogue og <alfa>glukosidaseinhibitor - Google Patents

Behandling av diabetes med tiazolidindion, insulin sekretagogue og <alfa>glukosidaseinhibitor

Info

Publication number
NO20000230D0
NO20000230D0 NO20000230A NO20000230A NO20000230D0 NO 20000230 D0 NO20000230 D0 NO 20000230D0 NO 20000230 A NO20000230 A NO 20000230A NO 20000230 A NO20000230 A NO 20000230A NO 20000230 D0 NO20000230 D0 NO 20000230D0
Authority
NO
Norway
Prior art keywords
thiazolidinedione
alfa
diabetes
treatment
glucosidase inhibitor
Prior art date
Application number
NO20000230A
Other languages
English (en)
Norwegian (no)
Other versions
NO20000230L (no
Inventor
Robin Edwin Buckingham
Stephen Alistair Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20000230L publication Critical patent/NO20000230L/no
Publication of NO20000230D0 publication Critical patent/NO20000230D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
NO20000230A 1997-07-18 2000-01-17 Behandling av diabetes med tiazolidindion, insulin sekretagogue og <alfa>glukosidaseinhibitor NO20000230D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9715298A GB9715298D0 (en) 1997-07-18 1997-07-18 Novel method of treatment
PCT/GB1998/002112 WO1999003478A1 (en) 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor

Publications (2)

Publication Number Publication Date
NO20000230L NO20000230L (no) 2000-01-17
NO20000230D0 true NO20000230D0 (no) 2000-01-17

Family

ID=10816170

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000230A NO20000230D0 (no) 1997-07-18 2000-01-17 Behandling av diabetes med tiazolidindion, insulin sekretagogue og <alfa>glukosidaseinhibitor

Country Status (27)

Country Link
EP (1) EP1001784A1 (xx)
JP (1) JP2001510160A (xx)
KR (1) KR20010021952A (xx)
CN (1) CN1263467A (xx)
AP (1) AP2000001735A0 (xx)
AR (2) AR016350A1 (xx)
AU (1) AU8449098A (xx)
BG (1) BG104062A (xx)
BR (1) BR9810292A (xx)
CA (1) CA2297133A1 (xx)
CO (1) CO4940489A1 (xx)
DZ (1) DZ2563A1 (xx)
EA (1) EA200000140A1 (xx)
GB (1) GB9715298D0 (xx)
HU (1) HUP0003626A3 (xx)
ID (1) ID23804A (xx)
IL (1) IL133907A0 (xx)
MA (1) MA24608A1 (xx)
NO (1) NO20000230D0 (xx)
OA (1) OA11312A (xx)
PE (1) PE99499A1 (xx)
PL (1) PL338140A1 (xx)
SK (1) SK612000A3 (xx)
TR (1) TR200000133T2 (xx)
UY (1) UY25101A1 (xx)
WO (1) WO1999003478A1 (xx)
ZA (1) ZA986364B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
ATE372782T1 (de) 1999-06-21 2007-09-15 Lilly Co Eli Synergitische verwendung von thiazolidinedionen und glucagon-ähnlichem peptid-1 und dessen agonisten für die behandlung von nicht-insulin- abhängigen diabetes
DK1248604T4 (da) * 2000-01-21 2012-05-21 Novartis Ag Kombinationer indeholdende dipeptidylpeptidase-IV-inhibitorer og antidiabetiske midler
JP4917712B2 (ja) * 2000-02-24 2012-04-18 武田薬品工業株式会社 併用医薬
WO2001062295A1 (fr) * 2000-02-24 2001-08-30 Takeda Chemical Industries, Ltd. Medicaments contenant des ingredients actifs combines
CA2434169C (en) 2001-01-12 2011-03-15 Sun Pharmaceutical Industries Limited Spaced drug delivery system
FR2832930A1 (fr) * 2001-12-03 2003-06-06 Lipha Composition pharmaceutique comprenant un inhibiteur d'alpha-glucosidase et un derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
WO2005041962A1 (en) 2003-10-31 2005-05-12 Takeda Pharmaceutical Company Limited Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester
CN101103993B (zh) * 2006-07-14 2011-03-30 北京华安佛医药研究中心有限公司 降糖药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2101866T3 (es) * 1991-08-26 1997-07-16 Upjohn Co Producto alimentario liquido que contiene acido 3-guanidinopropionico.
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes

Also Published As

Publication number Publication date
EA200000140A1 (ru) 2000-06-26
BG104062A (en) 2000-11-30
AR019724A2 (es) 2002-03-13
HUP0003626A3 (en) 2001-12-28
EP1001784A1 (en) 2000-05-24
PE99499A1 (es) 1999-12-18
AU8449098A (en) 1999-02-10
GB9715298D0 (en) 1997-09-24
IL133907A0 (en) 2001-04-30
CA2297133A1 (en) 1999-01-28
NO20000230L (no) 2000-01-17
BR9810292A (pt) 2000-09-19
AR016350A1 (es) 2001-07-04
WO1999003478A1 (en) 1999-01-28
ID23804A (id) 2000-05-11
CO4940489A1 (es) 2000-07-24
JP2001510160A (ja) 2001-07-31
OA11312A (en) 2003-10-24
ZA986364B (en) 2000-01-17
AP2000001735A0 (en) 2000-01-16
MA24608A1 (fr) 1999-04-01
UY25101A1 (es) 2000-12-29
CN1263467A (zh) 2000-08-16
DZ2563A1 (fr) 2003-02-15
PL338140A1 (en) 2000-09-25
KR20010021952A (ko) 2001-03-15
HUP0003626A2 (hu) 2001-05-28
TR200000133T2 (tr) 2000-09-21
SK612000A3 (en) 2000-07-11

Similar Documents

Publication Publication Date Title
DK0996444T3 (da) Behandling af diabetes med thiazolidindion og metformin
DK1228067T3 (da) 5-leddede heterocykliske forbindelser med hypoglykæmisk og hypolipidæmisk virkning
DK1183020T3 (da) (3-trihalogenmethylphenoxy)(4-halogenphenyl) til behandling af insulinresistens og type 2-diabetes
PL342517A1 (en) Methods of treating diabetes employing peptidic insulin analoques
DK1001783T3 (da) Behandling af diabetes med thiazolidindion, insulinsekretagog og biguanid
NO996265L (no) Behandling av diabetes med rosiglitazon og insulin
NO20000230D0 (no) Behandling av diabetes med tiazolidindion, insulin sekretagogue og &lt;alfa&gt;glukosidaseinhibitor
NO996270D0 (no) Behandling av diabetes med tiazolidindion og &lt;alfa&gt;- glukosidaseinhibitor
NO996264D0 (no) Behandling av diabetes med tiazolidindion og sulfonylurea
NO20000229L (no) Behandling av diabetes med tiazolidindion og sulfonylurea
HUP0002669A3 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
GB9812314D0 (en) Treatment of diabetes

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application